Altamira Therapeutics Ltd. — 20-F Filings
11 20-F filings on record
This page lists all 20-F filings submitted to the SEC by Altamira Therapeutics Ltd. (CYTOF), sorted by most recent first. Each row links to the full filing on EdgarLookup. Altamira Therapeutics Ltd. has filed 11 20-F documents with the SEC since 2014. To view all SEC filings by Altamira Therapeutics Ltd., see the full filings list.
All
15-12G
15F-12B
20-F
20-F/A
25-NSE
424B3
424B4
424B5
6-K
6-K/A
8-A12B
8-A12B/A
8-K12G3
CERT
CERTNAS
CORRESP
CT ORDER
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-4
F-4/A
FWP
NT 20-F
POS AM
POS EX
RW
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 20-F | ANNUAL REPORT | 0001213900-25-037199 | Apr 30, 2025 | Dec 31, 2024 |
| 20-F | ANNUAL REPORT | 0001213900-24-031734 | Apr 10, 2024 | Dec 31, 2023 |
| 20-F | ANNUAL REPORT | 0001213900-23-040152 | May 16, 2023 | Dec 31, 2022 |
| 20-F | ANNUAL REPORT | 0001213900-22-019292 | Apr 12, 2022 | Dec 31, 2021 |
| 20-F | ANNUAL REPORT | 0001213900-21-018959 | Mar 31, 2021 | Dec 31, 2020 |
| 20-F | ANNUAL REPORT | 0001213900-20-009292 | Apr 16, 2020 | Dec 31, 2019 |
| 20-F | 20-F | 0001601936-19-000008 | Mar 14, 2019 | Dec 31, 2018 |
| 20-F | 20-F | 0001601936-18-000007 | Mar 22, 2018 | Dec 31, 2017 |
| 20-F | FORM 20-F | 0000950103-17-002421 | Mar 14, 2017 | Dec 31, 2016 |
| 20-F | FORM 20-F | 0000950103-16-011830 | Mar 14, 2016 | Dec 31, 2015 |
| 20-F | FORM 20-F | 0000950103-15-002491 | Mar 31, 2015 | Dec 31, 2014 |